Eurofins-Cerep SA (EPA:ALECR)

Market Cap	82.22M -11.4%
Revenue (ttm)	41.10M +1.5%
Net Income	4.78M -33.2%
EPS	n/a
Shares Out	5.04K
PE Ratio	17.19
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5
Open	16,100
Previous Close	16,100
Day's Range	16,100 - 16,100
52-Week Range	15,300 - 18,600
Beta	0.01
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Eurofins-Cerep

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company also provides research services, including compound management, and high-throughout screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and is based in Celle-Lévescault, France. Eurofins-Cerep SA is a subsidiary of Eurofins Discovery Services LUX Holding SARL.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1989
• Employees: 197
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALECR

Financial Performance

In 2025, Eurofins-Cerep's revenue was 41.10 million, an increase of 1.51% compared to the previous year's 40.49 million. Earnings were 4.78 million, a decrease of -33.15%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 21, 2026

Data Sources Report a data error